APA (7th ed.) Citation

Kole, I. H., Vural, P., Yurdacan, B., Alemdar, A., & Mutlu, C. (2024). Evaluation of SLC6A2 and CYP2D6 polymorphisms’ effects on atomoxetine treatment in attention deficit and hyperactivity disorder. European Journal of Clinical Pharmacology, 80(11), 1773-1785. https://doi.org/10.1007/s00228-024-03744-z

Chicago Style (17th ed.) Citation

Kole, Ismail Hasan, Pınar Vural, Beste Yurdacan, Adem Alemdar, and Caner Mutlu. "Evaluation of SLC6A2 and CYP2D6 Polymorphisms’ Effects on Atomoxetine Treatment in Attention Deficit and Hyperactivity Disorder." European Journal of Clinical Pharmacology 80, no. 11 (2024): 1773-1785. https://doi.org/10.1007/s00228-024-03744-z.

MLA (9th ed.) Citation

Kole, Ismail Hasan, et al. "Evaluation of SLC6A2 and CYP2D6 Polymorphisms’ Effects on Atomoxetine Treatment in Attention Deficit and Hyperactivity Disorder." European Journal of Clinical Pharmacology, vol. 80, no. 11, 2024, pp. 1773-1785, https://doi.org/10.1007/s00228-024-03744-z.